Phenylacetylglutamine causes a pathologic inflammation state and enhances atherosclerosis through the b2-adrenergic receptor cAMP PKA NF-kappaB pathway in diabetes.
Event:
ESC Congress 2023
Topic:
Leukocytes, Inflammation, Immunity
Session:
Inflammatory mechanisms in vascular disease
